Crystalline methamphetamine use and methamphetamine‐related harms in Australia
- 11 June 2016
- journal article
- research article
- Published by Wiley in Drug and Alcohol Review
- Vol. 36 (2), 160-170
- https://doi.org/10.1111/dar.12426
Abstract
Introduction and Aims Concerns about crystal methamphetamine use and harm have increased in multiple countries. This paper describes how changes in the availability and use of crystal methamphetamine have impacted on methamphetamine‐related harms in Australia. Design and Methods Data on methamphetamine use were obtained from population‐level surveys, health service data and surveys of drug use among sentinel groups of ecstasy users and people who inject drugs. Data were obtained on seizures, arrests, clandestine laboratory detections, hospital separations, mental health unit admissions, drug telephone helpline calls and drug treatment episodes. Segmented linear regression models were fitted to identify changes in these series using log‐transformed data where appropriate. Results The availability of crystal methamphetamine has increased as evidenced by increased laboratory detections, domestic seizures and purity of the seized drug. Population surveys do not report an increase in the number of people who used at least once in the past year. However, more users report using crystal methamphetamine rather than lower‐purity powder methamphetamine and more regular use. Indicators of methamphetamine‐related harms have increased in parallel with this change. Amphetamine‐related helpline calls, drug treatment, arrests and hospital admissions for amphetamine disorders and psychosis all peaked in the mid‐2000s, declined for several years and have increased steeply since 2010. Discussion and Conclusions The increased availability and use of crystal methamphetamine have been associated with increased regular use and harms. Treatment is required for those experiencing problems and the capacity of health services to provide care needs to be enhanced.[Degenhardt L, Sara G, Connor JP, McKetin R, Roxburgh A, Dobbins T, Farrell M, Burns L, Hall WD. Crystalline methamphetamine use and methamphetamine‐related harms in Australia. Drug Alcohol Rev 2017;36:160–170]Keywords
This publication has 35 references indexed in Scilit:
- The risk of psychotic symptoms associated with recreational methamphetamine useDrug and Alcohol Review, 2010
- The rise of methamphetamine in Southeast and East AsiaDrug and Alcohol Review, 2008
- Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrantsDrug and Alcohol Review, 2008
- The epidemiology of methamphetamine use and harm in AustraliaDrug and Alcohol Review, 2008
- Substance-Induced PsychosisThe Journal of Clinical Psychiatry, 2008
- Methamphetamine and cardiovascular pathology: a review of the evidenceAddiction, 2007
- The prevalence of psychotic symptoms among methamphetamine usersAddiction, 2006
- HIV Risk Behavior Among Amphetamine Injectors at U.S. Syringe Exchange ProgramsAIDS Education and Prevention, 2005
- The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning systemDrug and Alcohol Review, 2002
- Stimulant Abuse Treatment as HIV PreventionJournal of Addictive Diseases, 1998